- ►chestpubs.org MN Levine, G Raskob, RJ Beyth, C Kearon, … - Chest, 2004 - chestjournal.chestpubs.org This chapter about hemorrhagic complications of anticoagulant treatment is part
of the seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy:
Evidence Based Guidelines. Bleeding is the major complication of ... Cited by 1081 - Related articles - BL Direct - All 14 versions
- ►chestpubs.org HR Büller, G Agnelli, RD Hull, TM Hyers, MH … - Chest, 2004 - chestjournal.chestpubs.org This chapter about antithrombotic therapy for venous thromboembolic disease is
part of the seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy:
Evidence Based Guidelines. Grade 1 recommendations are strong and indicate ... Cited by 920 - Related articles - BL Direct - All 9 versions
- ►chestpubs.org J Hirsh, R Raschke - Chest, 2004 - chestjournal.chestpubs.org This article about unfractionated heparin (UFH) and low-molecular-weight heparin
(LMWH) is part of the Seventh American College of Chest Physicians Conference on
Antithrombotic and Thrombolytic Therapy: Evidence-Based Guidelines. UFH is ... Cited by 562 - Related articles - BL Direct - All 6 versions
- ►ahajournals.org J Hirsh, SS Anand, JL Halperin, V Fuster - Circulation, 2001 - Am Heart Assoc Thrombi are composed of fibrin and blood cells and may form in any part of the
cardiovascular system, including veins, arteries, the heart, and the
microcirculation. Because the relative proportion of cells and fibrin ... Cited by 321 - Related articles - BL Direct - All 10 versions
- ►annals.org [PDF] HR Buller, BL Davidson, H Decousus, A … - Annals of internal medicine, 2004 - Am Coll Physicians Background: The current standard initial therapies for deep venous thrombosis
are low-molecular-weight heparin and unfrac- tionated heparin. In a dose-ranging
study of patients with symp- tomatic deep venous thrombosis, fondaparinux ... Cited by 237 - Related articles - BL Direct - All 13 versions
- ►annals.org [PDF] LA Linkins, PT Choi, JD Douketis - Annals of internal medicine, 2003 - Am Coll Physicians Background: Clinicians should consider the clinical impact of
anticoagulant-related bleeding when deciding on the duration of anticoagulant
therapy in patients with venous thromboembolism. Purpose: To provide ... Cited by 208 - Related articles - BL Direct - All 5 versions
C Kearon, SR Kahn, G Agnelli, S Goldhaber, … - Chest, 2008 - Am Coll Chest Phys Page 1. DOI 10.1378/chest.08-0658 2008;133;454S-545S Chest Gary E. Raskob and
Anthony J. Comerota Clive Kearon, Susan R. Kahn, Giancarlo ... Cited by 211 - Related articles - All 16 versions
- ►annals.org [PDF] DJ Quinlan, A McQuillan, JW Eikelboom - Annals of internal medicine, 2004 - Am Coll Physicians Page 1. Low-Molecular-Weight Heparin Compared with Intravenous Unfractionated
Heparin for Treatment of Pulmonary Embolism A Meta-Analysis ... Cited by 177 - Related articles - BL Direct - All 8 versions
GJCM Sanderink, CG Guimart, ML Ozoux, NU … - Thrombosis research, 2002 - Elsevier The pharmacokinetics of the low-molecular-weight heparin enoxaparin were
evaluated in 12 healthy volunteers and 36 patients with mild, moderate or severe
renal impairment. Enoxaparin was administered once daily by subcutaneous ... Cited by 109 - Related articles - All 7 versions
- ►nejm.org VF Tapson - Cardiology clinics, 2004 - Elsevier Pulmonary embolism (PE) occurs when venous thrombosis, usually from the deep
veins of the proximal legs, travels to the lungs causing a potential spectrum of
consequences, including dyspnea, chest pain, hypoxemia, and sometimes ... Cited by 109 - Related articles - BL Direct - All 29 versions
